business

Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity

Bloomberg Markets · Jul 1, 2026, 1:41 AM · Also reported by 1 other source

Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to people with knowledge of the matter.

Read full story on Bloomberg Markets → More top stories

Also covered by

Investing.com Main Street Capital increases credit facility to $1.24 billion

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity

Also covered by

More in business